These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22963934)

  • 41. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-drug resistant TB and HIV in Thailand: overlapping, but not independently associated risk factors.
    Akksilp S; Wattanaamornkiat W; Kittikraisak W; Nateniyom S; Rienthong S; Sirinak C; Ngamlert K; Mankatittham W; Sattayawuthipong W; Sumnapun S; Yamada N; Monkongdee P; Anuwatnonthakate A; Burapat C; Wells CD; Tappero JW; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1264-78. PubMed ID: 20578461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: A systematic review.
    Rajendran M; Zaki RA; Aghamohammadi N
    Tuberculosis (Edinb); 2020 May; 122():101925. PubMed ID: 32275233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
    Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
    Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.
    Kirenga BJ; Ssengooba W; Muwonge C; Nakiyingi L; Kyaligonza S; Kasozi S; Mugabe F; Boeree M; Joloba M; Okwera A
    BMC Public Health; 2015 Jan; 15():13. PubMed ID: 25604986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis.
    Sharma SK; Kaushik G; Jha B; George N; Arora SK; Gupta D; Singh U; Hanif M; Vashisht RP
    Indian J Med Res; 2011 Mar; 133(3):308-11. PubMed ID: 21441685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh.
    Rifat M; Hall J; Oldmeadow C; Husain A; Hinderaker SG; Milton AH
    BMJ Open; 2015 Sep; 5(9):e008273. PubMed ID: 26351185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
    Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
    Otero L; Krapp F; Tomatis C; Zamudio C; Matthys F; Gotuzzo E; Van der Stuyft P; Seas C
    PLoS One; 2011; 6(10):e26276. PubMed ID: 22046266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services.
    Arroyo LH; Yamamura M; Ramos ACV; Campoy LT; Crispim JA; Berra TZ; Alves LS; Alves YM; Dos Santos FL; Souza LLL; Bruce ATI; de Andrade HLP; Bollela VR; Krainski ET; Nunes C; Arcêncio RA
    Trop Med Int Health; 2020 Jul; 25(7):839-849. PubMed ID: 32358845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Underreported threat of multidrug-resistant tuberculosis in Africa.
    Ben Amor Y; Nemser B; Singh A; Sankin A; Schluger N
    Emerg Infect Dis; 2008 Sep; 14(9):1345-52. PubMed ID: 18759999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999-2018).
    Camphor HS; Viney K; Polkinghorne B; Pennington K
    Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients.
    Fleming MF; Krupitsky E; Tsoy M; Zvartau E; Brazhenko N; Jakubowiak W; McCaul ME
    Int J Tuberc Lung Dis; 2006 May; 10(5):565-70. PubMed ID: 16704041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.